baber/WOPTO huggingface dataset:
Patent NZ-289134-A (NZ)
Title: Method of improving the quality of plant seeds by spraying the plants, when the seed develop, with lactic acid bacterial preparation
Inventor: RELANDER HARALD
IPC: A01N63/20
Filed: 1995-07-05
Abstract: PCT No. PCT/FI95/00391 Sec. 371 Date Jan. 14, 1997 Sec. 102(e) Date Jan. 14, 1997 PCT Filed Jul. 5, 1995 PCT Pub. No. WO96/02141 PCT Pub. Date Feb. 1, 1996The invention relates to a method for improving the quality of the seeds of a plant by treating the plant, such as a cereal to be used in malting, with a lactic acid bacterial preparation. The treatment is performed in the field or under field conditions when the seeds develop by spraying the plant with the preparation. The invention also related to the use of the lactic acid bacterial preparation for spraying a plant in the field or under field conditions when its seeds develop. Furthermore, the invention relates to a plant product, such as a barley or rye product, which has been treated with the aforementioned method.
Patent NZ-303085-A (NZ)
Title: A topical composition containing at least one liquid lipid, a hydrous gel and an active ingredient which is soluble in at least one of the liquid lipids
Inventor: EISENREICH VOLKER
IPC: A61K31/57
Filed: 1996-03-14
Abstract: PCT No. PCT/AT96/00048 Sec. 371 Date Sep. 17, 1997 Sec. 102(e) Date Sep. 17, 1997 PCT Filed Mar. 14, 1996 PCT Pub. No. WO96/29056 PCT Pub. Date Sep. 26, 1996A topically applicable pharmaceutical composition comprises at least one liquid lipid, at least one pharmaceutical active ingredient which is soluble in at least one of the liquid lipids and is re-absorbed by the skin, and a hydrous gel which is the main component of the composition, whereby at least one lipid and at least one active ingredient are worked into the gel and the composition is essentially free of emulsifying agents and solid constituents, with the exception of the necessary gelatinizing agent required to form the hydrous gel. All of the active ingredients are present in dissolved form, whereby at least one active ingredient is dissolved in the liquid lipid, and this lipid containing the dissolved active ingredient is itself the internal phase and is worked into the hydrous gel as the external phase. The composition is also essentially free of surface-active substances. Process for manufacturing a topically applicable pharmaceutical composition of this kind which provides for the fact that at least one active ingredient re-absorbable by the skin is dissolved, preferably in concentrated form, in a lipid and that this solution is intermingled as the internal phase in a hydrous gel as the external phase, whereby this hydrous gel is the main component in the composition. The composition obtained thereby is highly stable and has favorable galenic properties.
Patent NZ-315089-A (NZ)
Title: Method for converting sparingly water-soluble medical substance to amorphous state
Inventor: MIYAMOTO MISAO
IPC: A61K9/00
Filed: 1996-08-08
Abstract: A method is provided for producing a solid dispersion of a sparingly water-soluble medical substance comprising the step of heat treating a mixture of the sparingly water-soluble medical substance, an amorphous state-inducing agent and an amorphous state-stabilising agent using a hot air dryer, a fluidized bed dryer, a gyro-dryer or a powder dryer at a temperature of not more than the melting point of the sparingly water-soluble medical substance for 20-120 minutes whereby the sparingly water-soluble medical substance is converted to the amorphous state. <??>Also provided is a method for producing a solid dispersion of a sparingly water-soluble medical substance comprising the step of microwave heating a mixture of the sparingly water-soluble medical substance, an amorphous state-stabilising agent and an amorphous state-inducing agent at a frequency of 915, 2450, 5800 or 22125 MHz for 3-40 minutes whereby the medical substance is converted to the amorphous state. <??>These processes make it possible to make sparingly water-soluble medical substance amorphous at a temperature lower than those employed in the conventional methods. The solid dispersions of the amorphous sparingly water-soluble medical substances thus obtained have an improved mucosal or rectal absorption rate, which makes it possible to elevate their bioavailability.
Patent NZ-332668-A (NZ)
Title: Endoscopes with sleeve having relatively low friction coefficient in forward direction and relatively high friction coefficient in rearward direction
Inventor: AXON ANTHONY THOMAS ROGER
IPC: A61B1/00
Filed: 1997-05-23
Abstract: A removable cover of an endoscope shaft (2) comprises a sleeve (4) of elastic material having a low friction external surface configured so that the frictional resistance to forward displacement of the endoscope shaft is less than the frictional resistance to reverse movement of the endoscope shaft.
Patent NZ-334511-A (NZ)
Title: Photocurable polymeric resin comprising a polyether-polybutadiene, hydroxyalkyl(meth)acrylate, alkyldialkanolamine, and a photoinitator
Inventor: KUMPFMILLER RONALD JAMES
IPC: G03F7/027
Filed: 1997-09-03
Abstract: Photopolymer resins comprise a reaction product of (i)	a polyether-polybutadiene prepolymer and a hydroxyalkyl(meth)acrylate further reacted with an alkyl-dialkanolamine and a solvent (ii)	a photoinitiator.  As general guidance in preparing compositions, the milliequivalents of isocyanate added should be equal to or greater than the total milliequivalents of the remaining components, namely polybutadiene, polyether diol, alkyldialkanolamine, and hydroxyalkyl(meth)acrylate. However, it is generally preferred that the ratio of milliequivalents of isocyanate to nonisocyanate components be approximately equal. Alkyldialanolamine generally is about 15-60% of the nonisocyanate components (based upon total milliequivalents) and preferably about 55-60%. Hydroxyalkyl(meth)acrylate makes up about 7-40% of the total nonisocyanate components, and preferably is about 8%.
Patent NZ-335753-A (NZ)
Title: TGF (transforming growth factor beta) beta 1-responsive cells from bone marrow
Inventor: GORDON ERLINDA MARIA
IPC: A61K35/12
Filed: 1997-11-12
Abstract: A method for expressing a recombinant protein from bone marrow-derived cells comprises the steps of treating the bone marrow-derived cells in vitro with a TGFbeta1 protein, which selects a population of the cells for further treatment. The selected cells can then be expanded, after which a gene encoding a therapeutic protein can be inserted into the expanded cells and thereafter express the therapeutic protein. The transduced cells can then be introduced into a mammal to produce a therapeutic result.
Patent NZ-336901-A (NZ)
Title: Electric fence controller, output level control used to enter access code to prevent unauthorised access and discourage theft
Inventor: HAMM VALERY
IPC: H05C1/00
Filed: 1999-07-23
Abstract: An electric fence controller 2 is fitted with a microprocessor that allows the fence controls to be used to enter an access code, so that the controller can only be operated by authorised persons, and so discourage theft.  The controller includes a rotary control 6 normally used for selecting the output energy level, a pushbutton 10 normally used for checking the state of charge of the battery, and LED 9 which indicates battery charge when pushbutton 10 is pressed.   When the controller is switched on, the LED will blink to indicate that the access code must be entered.  The code is entered by turning the rotary control to a setting, and pressing the button 10.  This is repeated until all of the digits in the access code have been entered.  The code entered is compared with a code stored in the controller's memory.  If the stored code matches the entered code this is indicated by the LED, and the controller will produce output to a fence.  If the codes do not match, this will be indicated by the LED, for example by blinking in a different colour, and the fence will not operate.  One of the positions of the rotary control may be a code change position, which indicates to the controller that the operator wishes to change the access code.  In this case the existing access code must be entered before it can be changed.
Patent NZ-502552-A (NZ)
Title: Polysiloxane block copolymers
Inventor: RUOHONEN JARKKO
IPC: C08G77/46
Filed: 1998-08-17
Abstract: A polysiloxane-based block copolymer of the formula T(AB)xAT wherein A = -(SiR'R''O)nSiR'R''-; R' and R'' represent an optionally substituted lower alkyl or phenyl group; B is polyalkylene oxide of formula -(CH2)yO(CRHCH2O)m(CH2)y- or -CH2CR1HCOO(CRHCH2O)mCOCR1HCH2-; T is CH2=CH(CH2)y-2O(CRHCH2O)m(CH2)y- or CH2=CR1COO (CRHCH2O)mCOCR1; R is hydrogen, lower alkyl, or phenyl; R1 is hydrogen or lower alkyl;  y is 2 - 6; m is 3 - 30; n is 5 - 3000; and x is 0 - 100.
Patent NZ-503524-A (NZ)
Title: Collar actuatable air valve for an air powered strap-tensioning tool where the collar is rotatable to open the valve against the bias of a collar biasing member
Inventor: ANGAROLA BARRY R
IPC: B65B13/18
Filed: 2000-03-21
Abstract: The collar actuatable air valve comprises a collar (130), rotatably coupled to a housing (120), having an inner portion (132) defining an actuator surface, and an air valve (10) disposed at least partially in the housing (120).  The air valve has an actuator portion (14) biased to protrude from the housing (120) and into engagement with the actuator surface of the collar (130).  A collar biasing member is disposed between the collar (130) and the housing (120) to rotatably bias the collar to close the air valve (as shown in figure 2).  The collar is however rotatable against the bias of the collar biasing member to open the air valve (as shown in figure 3).
Patent NZ-505167-A (NZ)
Title: Silicon with structured oxygen doping, its production and use
Inventor: HABLER CHRISTIAN
IPC: H01L31/04
Filed: 2000-06-14
Abstract: Silicon and a process for producing silicon having a total oxygen content of 8x1017 atoms/cm3 to 1x1019 atoms/cm3 and a dislocation density of 1x105 cm-2 to 5x107 cm-2.  The silicon has at least 25% of the oxygen contained in the form of silicon/oxygen precipitations that are concentrated in the area of the grain boundaries and dislocations.  The process involves molten silicon being in contact with silicon monoxide and/or silicon dioxide therefore becoming saturated with oxygen, and/or the molten silicon is treated with an oxygen-containing gas before or during the crystallization.  The dislocation density is set by means of the cooling rate of the silicon.  The silicon finds use in film-casting or film drawing processes and in photovoltaics.
Patent NZ-507925-A (NZ)
Title: Tear resistant porous extensible web
Inventor: CURRO JOHN JOSEPH
IPC: A61F13/511
Filed: 1999-05-25
Abstract: The present invention pertains to a porous, macroscopically-expanded, three-dimensional, elastomeric web suitable for use in disposable absorbent articles such as bandages, diapers and pull-up diaper training pants, as well as a method for making the web. In a preferred embodiment the web has a continuous first surface and a discontinuous second surface remote from first surface. In a preferred embodiment the elastomeric web exhibits a multiplicity of primary apertures in the first surface of the web, the primary apertures being defined in the plane of the first surface by a continuous network of interconnecting members. Each interconnecting member exhibits an upwardly concave-shaped cross section along its length. The interconnecting members terminate substantially concurrently with one another to form a secondary aperture in the plane of the second surface of the web.
Patent NZ-508258-A (NZ)
Title: Method for creating an optically smooth surface on a display
Inventor: SEARLE MARK JOHN
IPC: H01J15/00
Filed: 2000-11-17
Abstract: A method, for converting the matt surface, of the front screen of a multi focal-plane display, to an optically smooth surface. The smooth surface maybe achieved through the application of a transparent coating or a transparent adhesive film of the same or similar refractive index to the screen.
Patent NZ-510649-A (NZ)
Title: Interrogation and responder system
Inventor: GERBER PETER
IPC: G01S13/78
Filed: 2001-03-20
Abstract: An interrogator 10/responder 20 system includes an interrogator transmitter 11 that emits short pulses of electromagnetic energy of at least GHz frequency modulated in time and direction fro antenna 12.  The responder receiver 21 is tuned to receive and demodulate the pulse energy, and to evaluate the demodulated signal.  In accordance with a decision made by the evaluation unit 25, the transmitter 26 of the responder transmits a reply signal to the receiver 16 of the interrogator unit 10.  The system is useful for determination of status of participants in battle simulations.
Patent NZ-511325-A (NZ)
Title: Prefabricated girder in two halves and roof structure
Inventor: METELLI LUIGI
IPC: E04B1/21
Filed: 2000-08-02
Abstract: The invention concerns a girder in reinforced concrete that has a flat intrados (not shown) and a flat or sloping extrados (not shown), which consists of two symmetrical halves or half-girders (13, 14), with adjacent parts that meet in a plane mid-way (15), perpendicular to the intrados, and equipped, near the extrados (not shown), with connecting plates for bolting (not shown) and, near the intrados (not shown), with a joint device (17) that has bars which are parallel to the intrados.
Patent NZ-516781-A (NZ)
Title: Topical organic ectoparasiticidal formulations
Inventor: KASSEBAUM JAMES WEB
IPC: A61K9/00
Filed: 2000-07-26
Abstract: Topical  ectoparasiticidal formulations comprising  an ectoparasiticide, preferably a pyrethroid or a  spinosyn,  a spreading agent that is preferably isopropyl myristate,  and optionally  a  miscibilizing agent compatible  with  organic solvent  systems, and methods of controlling an ectoparasite infestation   on   certain  animals   comprising   topically applying such formulations to the animal.
Patent NZ-522774-A (NZ)
Title: Accessory for modular elements for the support and ventilation of crawl spaces, floor structures, floors or similar articles in the building field
Inventor: PONTAROLO VALERIO
IPC: E04F15/024
Filed: 2001-05-09
Abstract: Accessory (20) for modular elements (10) for the support and ventilation of crawl spaces, floor structures, floors or similar articles in the building field, each comprising an upper horizontal wall (11) and a plurality of vertical supporting legs (13) defining a continuous passage below the upper wall, the accessory comprising a front wall (21) and a lateral wall (22) having a profile mating with that of the aperture defined by each pair of vertical legs of a modular element.
Patent NZ-523649-A (NZ)
Title: Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches
Inventor: BEERLI ROGER
IPC: C07K19/00
Filed: 2001-07-16
Abstract: A non-naturally occurring polypeptide comprising two ligand binding domains derived from nuclear hormone receptors operatively linked to a first functional domain.
Patent NZ-528033-A (NZ)
Title: Method for treating and drying of wood
Inventor: HOTTINEN ARI
IPC: B27M1/02
Filed: 2002-02-11
Abstract: A method for treatment and drying of wood, in which method the wood is warmed up to an essentially higher temperature than the boiling point of water, where after the wood is compressed between moisture permeable pressing pieces. The method is characterized in that the temperature of the wood is increased so quickly, that the moisture existing in the wood does not have the time to evaporate to an essential degree before the temperature of the wood has increased above the boiling point of water. In a method of drying of timber of this kind for the building-up of the steam atmosphere needed does not require separately from the outside brought water for the producing of the steam, but the steam needed for the building-up of the steam atmosphere is produced in the pressing phase out of the moisture leaving the wood. In such a way energy is saved and the apparatuses needed for the method are got more simple and favourable than the apparatuses used earlier for a corresponding purpose.
Patent NZ-528552-A (NZ)
Title: Methods of preparing a library of polynucleotides comprising contacting the parent set with at least one class IIS restriction enzyme
Inventor: DELAGRAVE SIMON
IPC: C12N15/10
Filed: 2002-04-04
Abstract: Methods of directed fragmentation of polynucleotides combined with fragment interchange and ligation are provided for the preparation of polynucleotide libraries as shown in figure 1. Fragmentation can be facilitated by at least one oligonucleotide adapter capable of directing polynucleotide cleavage at homologous sites among a set of parent polynucleotides. Libraries generated by the above methods can be screened for polynucleotides with desired characteristics or properties.
Patent NZ-531384-A (NZ)
Title: Insect control device for prolonged treatment of animals containing coumaphos and diazinon
Inventor: ARTHER ROBERT G
IPC: A01M29/30
Filed: 2002-08-28
Abstract: An insect control device for attachment to animals which effectively releases insect controlling agents for a period of up to about four months comprising a molded article formed from a mixture of coumaphos and diazinon, polyvinyl chloride, and a plasticizer.
Patent NZ-535365-A (NZ)
Title: Phosphate prodrugs of fluorooxindoles
Inventor: GILLMAN KEVIN W
IPC: A61P25/28
Filed: 2003-03-20
Abstract: A compound of the formula I, or a non-toxic pharmaceutically acceptable salt or solvate thereof, is disclosed. A is a direct bond or (C=O); B is a direct bond, oxygen or nitrogen; m is 0 or 1; n is 1, 2 or 3; R1 and R2 each are independently hydrogen or a hydrolyzable ester group; and when R1 is hydrogen, R2 may also be -P(O)OR5OR6 or heteroaryl; R3 and R4 each are independently hydrogen or C1-4 alkyl; and R5 and R6 each are independently hydrogen or a hydrolyzable ester group. A pharmaceutical composition containing the compound of formula I is described to be for the treatment of disorders responsive to openers of the large conductance calcium- activated potassium channels. Such disorders include ischemia, stroke, epilepsy and asthma.
Patent NZ-537662-A (NZ)
Title: 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
Inventor: SOMMADOSSI JEAN-PIERRE
Filed: 2003-06-27
Abstract: Disclosed is a compound of formula I or a pharmaceutically acceptable salt thereof. Compounds of the type disclosed are useful in the treatment of flaviviridae infections, in particular hepatitis C. Also disclosed are combination therapies comprising said compound.
Patent NZ-544475-A (NZ)
Title: Media comprising gellan gum and methods for promoting maturation of conifer somatic embryos
Inventor: HOLMSTROM DIANE G
IPC: C12Q1/68
Filed: 2004-06-14
Abstract: A method for producing mature conifer somatic embryos is disclosed, wherein the method of comprise the steps of: (a) culturing pre-cotyledonary conifer somatic embryos in, or on, a development medium comprising less than 0.5% of gellan gum to form cotyledonary conifer somatic embryos; and (b) culturing cotyledonary conifer somatic embryos formed in step (a) in, or on, a maturation medium comprising between about 0.5% to about 1.5% of gellan gum and about 1% to about 6% sucrose to produce mature conifer somatic embryos. In some embodiments, the maturation medium further comprises abscisic acid.
Patent NZ-545232-A (NZ)
Title: Sealing of bacterial ghosts by means of bioaffinity interactions
Inventor: LUBITZ WERNER
IPC: C12N1/21
Filed: 2004-08-05
Abstract: Provided is a method for preparing closed bacterial ghosts, comprising fusing bacterial ghosts with carrier materials under conditions under which closure of the bacterial ghosts takes place, wherein, the fusion is mediated by way of specific interactions between the partners of a bioaffinity binding pair, which partners are anchored on the ghosts and/or the carrier materials. Further provided are similar methods wherein the bioaffinity partners are antibodies and other specified molecules. Further provided are compositions of closed bacterial ghosts.
Patent NZ-547850-A (NZ)
Title: System and method for network discovery and connection management
Inventor: MCALLEN CHRISTOPHER M
IPC: G16H10/60
Filed: 2004-12-01
Abstract: A method and system for determining the status of a client device connected to a network in order to manage patient care in an institution are disclosed. The method comprises the steps of: operating a server connected to the network to wirelessly broadcast an encrypted beacon signal over the network from a selected port of the server, operating a client that is connected to the network to receive the encrypted beacon signal over the network to the selected port for reception by the server, the response signal including a list of endpoints for use by the server to open a communication session with the client. Only the server broadcasts the encrypted beacon signal, the client does not.
Patent NZ-549895-A (NZ)
Title: Vacuum cleaner with electronic controller configured to be installed through aperture in base
Inventor: ZAHURANEC TERRY L
Filed: 2006-09-15
Abstract: A cleaning apparatus includes a base. The base has a bottom surface, an access opening in the bottom surface, and wheels for wheeling the base over a floor while the bottom surface faces the floor. A cleaning attachment is configured to be attached to the base and moved against a household surface to clean the surface. An electronic controller is configured to be inserted through the opening into an installed position in the base from which to control an operating condition of the apparatus.
Patent NZ-551719-A (NZ)
Title: Biodegradable polymeric water retention concentrate
Inventor: TURLEY GEOFF
IPC: C05G3/80
Filed: 2005-06-22
Abstract: Disclosed is a composition for treating plan growing media such as soil, where the composition includes a linear acrylamide copolymer, and optionally includes a water softener, a surfactant, and nutrients.
Patent NZ-561392-A (NZ)
Title: Coupler lock
Inventor: KALOUS SCOTT
IPC: B60D1/60
Filed: 2006-03-14
Abstract: An assembly 10 for restricting access to a coupler includes a body 18 configured for engagement with at least one surface of the coupler, a coupler ball 14 movably coupled to the body 18 and configured for engagement with a ball cavity of the coupler, and a securing mechanism 16.The securing mechanism 16 can fix the position of the coupler ball 14 relative to the body such that the assembly is secured to the coupler. The assembly allows the use of different coupler balls.
Patent NZ-564205-A (NZ)
Title: Heart valve prothesis with leaflets affixed to a skirt, free edges of the leaflets defining the shape of catenaries
Inventor: NGUYEN THAN
IPC: A61F2/24
Filed: 2006-05-12
Abstract: Disclosed is a valve prosthesis. The prosthesis has a valve body (14) including a plurality of leaflets (22) affixed to a skirt (21), adjoining leaflets affixed together to form commissures (24); and a frame (12) supporting the valve body, the frame having a longitudinal axis. The commissures are affixed to the frame along a region of the frame that increases in diameter along the longitudinal axis. Each leaflet has a free edge (25) that is suspended from the leaflet's respective commissures to define coaptation edges and a centre of coaptation (26), with the commissures being longitudinally offset from the center of coaptation. The length of each free edge of the leaflets includes a continuous curve (27) extending downwardly between the respective commissures so that the free edges of the leaflets define the shape of catenaries to uniformly distribute loads over the leaflets.